Table of Contents
ISRN Gastroenterology
Volume 2014 (2014), Article ID 619628, 5 pages
http://dx.doi.org/10.1155/2014/619628
Research Article

Comparison of Laboratory Data of Acute Cholangitis Patients Treated with or without Immunosuppressive Drugs

1Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan
2Department of Radiology, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan
3Department of Surgery, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan
4Department of Neurology, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan
5Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan
6Department of Pediatrics, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido City, Chiba 284-0003, Japan

Received 8 January 2014; Accepted 5 March 2014; Published 10 March 2014

Academic Editors: A. J. Karayiannakis, A. Mencarelli, and L. Rodrigo

Copyright © 2014 Minoru Tomizawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Mosler, “Management of acute cholangitis,” Gastroenterology and Hepatology, vol. 7, no. 2, pp. 121–123, 2011. View at Google Scholar · View at Scopus
  2. M. K. Sahu, A. Chacko, A. K. Dutta, and J. A. J. Prakash, “Microbial profile and antibiotic sensitivity pattern in acute bacterial cholangitis,” Indian Journal of Gastroenterology, vol. 30, no. 5, pp. 204–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. W. Kim, H. C. Shin, H. C. Kim et al., “Diagnostic performance of multidetector CT for acute cholangitis: evaluation of a CT scoring method,” The British Journal of Radiology, vol. 85, no. 1014, pp. 770–777, 2012. View at Google Scholar
  4. W. A. Qureshi, “Approach to the Patient Who Has Suspected Acute Bacterial Cholangitis,” Gastroenterology Clinics of North America, vol. 35, no. 2, pp. 409–423, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Yoneyama, H. Saito, T. Kurihara et al., “Factors involved in resistance to early treatment of acute cholangitis patients,” Hepatogastroenterology, vol. 59, no. 118, pp. 1722–1726, 2012. View at Google Scholar
  6. P. Mosler, “Diagnosis and management of acute cholangitis,” Current Gastroenterology Reports, vol. 13, no. 2, pp. 166–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Wada, T. Takada, Y. Kawarada et al., “Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 14, no. 1, pp. 52–58, 2007. View at Google Scholar
  8. S. Kiriyama, T. Takada, S. M. Strasberg et al., “New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, no. 5, pp. 548–556, 2012. View at Google Scholar
  9. J. G. Lee, “Diagnosis and management of acute cholangitis,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 9, pp. 533–541, 2009. View at Google Scholar
  10. M. Sugiyama and Y. Atomi, “Treatment of acute cholangitis due to choledocholithiasis in elderly and younger patients,” Archives of Surgery, vol. 132, no. 10, pp. 1129–1133, 1997. View at Google Scholar · View at Scopus
  11. M. M. Shahshahani, S. Azizahari, T. Soori et al., “Hepatotoxicity and liver enzyme alteration in patients with immunobullous diseases receiving immunosuppressive therapy,” Journal of Dermatology, vol. 38, no. 12, pp. 1153–1157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Davila-Fajardo, J. J. Swen, J. Cabeza Barrera et al., “Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate,” Pharmacogenomics, vol. 14, no. 1, pp. 63–73, 2013. View at Google Scholar
  13. J. M. Senabre-Gallego, C. Santos-Ramirez, G. Santos-Soler et al., “Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis,” Patient Prefer Adherence, vol. 7, pp. 961–972, 2013. View at Google Scholar
  14. M. Ghabril, H. L. Bonkovsky, C. Kum et al., “Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases,” Clinical Gastroenterology and Hepatology, vol. 11, no. 5, pp. 558–564, 2013. View at Google Scholar
  15. D. K. Rosing, C. de Virgilio, A. T. Nguyen, M. El Masry, A. H. Kaji, and B. E. Stabile, “Cholangitis: analysis of admission prognostic indicators and outcomes,” The American Surgeon, vol. 73, no. 10, pp. 949–954, 2007. View at Google Scholar · View at Scopus
  16. M. Nio and T. Muraji, “Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia,” Pediatric Surgery International, vol. 29, no. 11, pp. 1091–1095, 2013. View at Google Scholar
  17. N. Ali, S. Rashid, S. Nafees et al., “Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis,” Molecular and Cellular Biochemistry, vol. 385, no. 1-2, pp. 215–223, 2014. View at Google Scholar
  18. L. Puglielli, L. Amigo, M. Arrese et al., “Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage,” Gastroenterology, vol. 107, no. 1, pp. 244–254, 1994. View at Google Scholar · View at Scopus
  19. S. A. Center, “Chronic liver disease: current concepts of disease mechanisms,” Journal of Small Animal Practice, vol. 40, no. 3, pp. 106–114, 1999. View at Google Scholar · View at Scopus